CD163 and neoplasm: In fact, expression of CD163 on breast cancer cells as well as rectal cancer cells was associated with early recurrences and a reduced survival time [34,35], which is generally in view with the concept that tumor cell × normal cell hybrids may exhibit a more malignant phenotype [3,4,5].